HOME
ABOUT
About TAXIS
Founders
Management
Board of Directors
Scientific Advisors
PIPELINE
The Antibiotic Resistance Crisis
Our Pipeline
Research & Development
Publications
NEWS & EVENTS
News Releases
Events
PARTNERSHIPS
FCOI
CONTACT
An FtsZ-Targeting Prodrug with Oral Antistaphylococcal Efficacy
in Vivo
.
Post navigation
Pharmacokinetics and
in Vivo
Antistaphylococcal Efficacy of TXY541, a 1-Methylpiperidine-4-Carboxamide Prodrug of PC190723.
Enterococcal and Streptococcal Resistance to PC190723 and Related Compounds: Molecular Insights from a FtsZ Mutational Analysis.